Risk in complex genetics: "all models are wrong but some are useful"

Annals of Neurology

Volumn 72, Issue 4, 2012, Pages 502-509

  Sawcer, Stephen ^a   Wason, James ^b  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MRC BIOSTATISTICS UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOCYTE ANTIGEN;

ARTICLE; GENE LOCUS; GENE MAPPING; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; MATHEMATICAL MODEL; MORBIDITY; MULTIPLE SCLEROSIS; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; ENVIRONMENT; GENE FREQUENCY; GENETIC LINKAGE; GENETIC PREDISPOSITION TO DISEASE; GENETICS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MODELS, NEUROLOGICAL; NERVOUS SYSTEM DISEASES; NEUROBIOLOGY; ODDS RATIO; RISK FACTORS;

EID: 84868212192     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.23613     Document Type: Article

References (35)

1. Clayton DG,. Prediction and interaction in complex disease genetics: experience in type 1 diabetes. PLoS Genet 2009; 5: e1000540.
2. Fisher RA,. The correlation between relatives on the supposition of Mendelian inheritance. Philos Trans R Soc Edinb 1918; 52: 399-433.
3. Pharoah PD, Antoniou AC, Easton DF, Ponder BA,. Polygenes, risk prediction, and targeted prevention of breast cancer. N Engl J Med 2008; 358: 2796-2803.
4. Janssens AC, Ioannidis JP, van Duijn CM, et al. Strengthening the reporting of genetic risk prediction studies: the GRIPS Statement. Ann Intern Med 2011; 154: 421-425.
5. International Multiple Sclerosis Genetics Consortium (IMSGC) and Wellcome Trust Case Control Consortium,2 (WTCCC2). Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 2011; 476: 214-219.
6. Robertson NP, Fraser M, Deans J, et al. Age-adjusted recurrence risks for relatives of patients with multiple sclerosis. Brain 1996; 119 (pt 2): 449-455.
7. Sawcer S, Ban M, Wason J, Dudbridge F,. What role for genetics in the prediction of multiple sclerosis? Ann Neurol 2010; 67: 3-10.
8. Robertson NP, O'Riordan JI, Chataway J, et al. Offspring recurrence rates and clinical characteristics of conjugal multiple sclerosis. Lancet 1997; 349: 1587-1590.
9. Mumford CJ, Wood NW, Kellar-Wood H, et al. The British Isles survey of multiple sclerosis in twins. Neurology 1994; 44: 11-15.
10. Hedstrom AK, Sundqvist E, Baarnhielm M, et al. Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. Brain 2011; 134: 653-664.
11. Kraft P, Wacholder S, Cornelis MC, et al. Beyond odds ratios-communicating disease risk based on genetic profiles. Nat Rev Genet 2009; 10: 264-269.
12. Lee SH, Wray NR, Goddard ME, Visscher PM,. Estimating missing heritability for disease from genome-wide association studies. Am J Hum Genet 2011; 88: 294-305.
13. Levin LI, Munger KL, Rubertone MV, et al. Temporal relationship between elevation of Epstein-Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 2005; 293: 2496-2500.
14. Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006; 296: 2832-2838.
15. Hawkes CH,. Smoking is a risk factor for multiple sclerosis: a metanalysis. Mult Scler 2007; 13: 610-615.
16. Doll R, Hill AB,. Smoking and carcinoma of the lung; preliminary report. Br Med J 1950; 2: 739-748.
17. Australo-Anglo-American Spondyloarthritis Consortium (TASC) and Wellcome Trust Case Control Consortium,2 (WTCCC2). Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet 2011; 43: 761-767.
18. Dejesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011; 72: 245-256.
19. Risch N, Merikangas K,. The future of genetic studies of complex human diseases. Science 1996; 273: 1516-1517.
20. International Multiple Sclerosis Genetics Consortium (IMSGC),. A high-density screen for linkage in multiple sclerosis. Am J Hum Genet 2005; 77: 454-467.
21. McCarthy MI, Abecasis GR, Cardon LR, et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 2008; 9: 356-369.
22. Nejentsev S, Walker N, Riches D, et al. Rare variants of IFIH1, a gene implicated in antiviral responses, protect against type 1 diabetes. Science 2009; 324: 387-389.
23. Ramagopalan SV, Dyment D, Cader MZ, et al. Rare variants in the CYP27B1 gene associated with multiple sclerosis. Ann Neurol 2011; 70: 881-886.
24. Anderson CA, Soranzo N, Zeggini E, Barrett JC,. Synthetic associations are unlikely to account for many common disease genome-wide association signals. PLoS Biol 2011; 9: e1000580.
25. Dickson SP, Wang K, Krantz I, et al. Rare variants create synthetic genome-wide associations. PLoS Biol 2010; 8: e1000294.
26. Zuk O, Hechter E, Sunyaev SR, Lander ES,. The mystery of missing heritability: genetic interactions create phantom heritability. Proc Natl Acad Sci U S A 2012; 109: 1193-1198.
27. Hawkes CH, Macgregor AJ,. Twin studies and the heritability of MS: a conclusion. Mult Scler 2009; 15: 661-667.
28. Manolio TA, Collins FS, Cox NJ, et al. Finding the missing heritability of complex diseases. Nature 2009; 461: 747-753.
29. Pharoah PD, Antoniou A, Bobrow M, et al. Polygenic susceptibility to breast cancer and implications for prevention. Nat Genet 2002; 31: 33-36.
30. Hemminki K, Li X, Sundquist J, et al. Risk for multiple sclerosis in relatives and spouses of patients diagnosed with autoimmune and related conditions. Neurogenetics 2009; 10: 5-11.
31. Gourraud PA, McElroy JP, Caillier SJ, et al. Aggregation of multiple sclerosis genetic risk variants in multiple and single case families. Ann Neurol 2011; 69: 65-74.
32. Ebers GC,. A twin consensus in MS. Mult Scler 2005; 11: 497-499.
33. Aulchenko YS, Struchalin MV, Belonogova NM, et al. Predicting human height by Victorian and genomic methods. Eur J Hum Genet 2009; 17: 1070-1075.
34. Rose G,. Sick individuals and sick populations. Int J Epidemiol 1985; 14: 32-38.
35. Box GEP, Draper NR,. Empirical model-building and response surface. New York, NY: John Wiley & Sons, 1986.